Literature DB >> 23891180

Self-efficacy and fear avoidance beliefs in chronic low back pain patients: coexistence and associated factors.

Erica Brandão de Moraes Vieira1, Marina de Góes Salvetti2, Lucas Petri Damiani2, Cibele Andrucioli de Mattos Pimenta2.   

Abstract

A cross sectional study was conducted with the objective to assess the coexistence of self-efficacy and fear avoidance beliefs and establish the associated factors. Data collection was performed (215 individuals with lower back pain at three health services and two industries). The following instruments were used: Tampa Scale for Kinesiophobia, Beck's Depression Inventory, Piper's Fatigue Scale, Oswestry Disability Index, and the Chronic Pain Self-Efficacy Scale. Wilks' lambda test was performed, followed by MANOVA model to assess the effect of self-efficacy beliefs and fear avoidance on independent variables. Most subjects were women (65.1%), 45 years of age or younger (50.7%), with a family income between $450 and $1,350 per month (49.3%). Depression was present in 21.4%, fatigue in 29.3%, and disability in 68%. The average (standard deviation) of self-efficacy was 180.8 (60.4), and fear avoidance was 42.0 (11.5). A significant negative correlation was observed between the total score of both beliefs. The Wilks' lambda test showed that gender, income, depression, disability, and fatigue were significant and were included in the model. In the Manova analysis, low self-efficacy was associated with lower income, fatigue, depression, and level of disability (p < .001). High fear avoidance was associated to the male gender, lower income, depression, and level of disability (p < .001). The analysis of the confidence areas showed that a reduced self-efficacy and increased fear avoidance are related to an increased level of disability (p < .001). Specific intervention strategies must be implemented change these beliefs.
Copyright © 2014 American Society for Pain Management Nursing. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23891180     DOI: 10.1016/j.pmn.2013.04.004

Source DB:  PubMed          Journal:  Pain Manag Nurs        ISSN: 1524-9042            Impact factor:   1.929


  19 in total

1.  Association Between 6-Week Postdischarge Risk Classification and 12-Month Outcomes After Orthopedic Trauma.

Authors:  Renan C Castillo; Yanjie Huang; Daniel Scharfstein; Katherine Frey; Michael J Bosse; Andrew N Pollak; Heather A Vallier; Kristin R Archer; Robert A Hymes; Anna B Newcomb; Ellen J MacKenzie; Stephen Wegener; Joseph R Hsu; Madhav A Karunakar; Rachel B Seymour; Stephen H Sims; Eileen Flores; Christine Churchill; David J Hak; Corey E Henderson; Hassan R Mir; Daniel S Chan; Anjan R Shah; Barbara Steverson; Jerald Westberg; Joshua L Gary; Timothy S Achor; Andrew Choo; John W Munz; Melissa Porrey; Sarah Hendrickson; Mary A Breslin; Todd O McKinley; Greg E Gaski; Laurence B Kempton; Anthony T Sorkin; Walter W Virkus; Lauren C Hill; Clifford B Jones; Debra L Sietsema; Robert V O'Toole; Katherine Ordonio; Andrea L Howe; Timothy J Zerhusen; William Obremskey; Robert H Boyce; A Alex Jahangir; Cesar S Molina; Manish K Sethi; Susan W Vanston; Eben A Carroll; Danielle Yemiola Drye; Martha B Holden; Susan C Collins; Elizabeth Wysocki
Journal:  JAMA Surg       Date:  2019-02-20       Impact factor: 14.766

2.  Comparative study of PROMIS self-efficacy for managing chronic conditions across chronic neurologic disorders.

Authors:  Lisa M Shulman; Craig Velozo; Sergio Romero; Ann L Gruber-Baldini
Journal:  Qual Life Res       Date:  2019-03-26       Impact factor: 4.147

3.  Income as a Predictor of Self-Efficacy for Managing Pain and for Coping With Symptoms Among Patients With Chronic Low Back Pain.

Authors:  Margaret D Whitley; Patricia M Herman; Gursel R Aliyev; Cathy D Sherbourne; Gery W Ryan; Ian D Coulter
Journal:  J Manipulative Physiol Ther       Date:  2021-08-29       Impact factor: 1.300

4.  The Swedish Exercise Self-Efficacy Scale (ESES-S): reliability and validity in a rheumatoid arthritis population.

Authors:  Thomas Nessen; Ingrid Demmelmaier; Birgitta Nordgren; Christina H Opava
Journal:  Disabil Rehabil       Date:  2015-09-04       Impact factor: 3.033

5.  Cognitive Functional Therapy: An Integrated Behavioral Approach for the Targeted Management of Disabling Low Back Pain.

Authors:  Peter B O'Sullivan; J P Caneiro; Mary O'Keeffe; Anne Smith; Wim Dankaerts; Kjartan Fersum; Kieran O'Sullivan
Journal:  Phys Ther       Date:  2018-05-01

6.  Effects of lumbar extensor muscle strengthening and neuromuscular control retraining on disability in patients with chronic low back pain: a protocol for a randomised controlled trial.

Authors:  Joshua Brodie Farragher; Adrian Pranata; Gavin Williams; Doa El-Ansary; Selina M Parry; Jessica Kasza; Adam Bryant
Journal:  BMJ Open       Date:  2019-08-19       Impact factor: 2.692

7.  Is there a relationship between self-efficacy, disability, pain and sociodemographic characteristics in chronic low back pain? A multicenter retrospective analysis.

Authors:  Silvano Ferrari; Carla Vanti; Marta Pellizzer; Luca Dozza; Marco Monticone; Paolo Pillastrini
Journal:  Arch Physiother       Date:  2019-10-12

8.  Strategies for Coping with Chronic Lower Back Pain in Patients with Long Physiotherapy Wait Time.

Authors:  Anna Cabak; Anna Dąbrowska-Zimakowska; Aleksandra Truszczyńska; Patryk Rogala; Katarzyna Laprus; Wiesław Tomaszewski
Journal:  Med Sci Monit       Date:  2015-12-15

9.  Fear and difficulty perceived when visualizing therapeutic exercise in patients with chronic low back pain: A cross-sectional study.

Authors:  Marcos Pérez-Fernández; Sergio Lerma-Lara; Raúl Ferrer-Peña; Alfonso Gil-Martínez; Ibai López-de-Uralde-Villanueva; Alba Paris-Alemany; Héctor Beltrán-Alacreu; Roy La Touche
Journal:  J Exerc Rehabil       Date:  2015-12-31

10.  The translation, validity and reliability of the German version of the Fremantle Back Awareness Questionnaire.

Authors:  Katja Ehrenbrusthoff; Cormac G Ryan; Christian Grüneberg; Benedict M Wand; Denis J Martin
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.